Ubisoft Delays XDefiant Release Indefinitely: Call Of Duty-Style Game Faces Ongoing Challenges
Portfolio Pulse from Franca Quarneti
Ubisoft Entertainment SA (OTC:UBSFF) has indefinitely delayed the release of its first-person shooter game, XDefiant, due to persistent issues. The game, often compared to Activision Blizzard Inc's (NASDAQ:ATVI) Call of Duty, failed console quality control tests and showed inconsistencies during public test sessions. Ubisoft has not provided a new release date but is committed to resolving the issues.
October 11, 2023 | 9:27 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The delay of Ubisoft's XDefiant, a competitor to Activision's Call of Duty, could potentially benefit Activision in the short term.
With Ubisoft's XDefiant facing delays, gamers might turn to similar games like Activision's Call of Duty. This could potentially increase Activision's short-term sales and market share.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 50
NEGATIVE IMPACT
Ubisoft's indefinite delay of XDefiant could negatively impact the company's short-term revenues and reputation among gamers.
The delay of a major game release like XDefiant can lead to a temporary decrease in revenues. Additionally, persistent issues and delays can harm the company's reputation among gamers, potentially affecting future sales.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100